# Armata Pharmaceuticals, Inc. (ARMP)

> Source: Nexqual · https://nexqual.com/ARMP · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Armata Pharmaceuticals, Inc. (ARMP), nexqual.com/ARMP" · informational, not investment advice.

**Price:** USD 3.09 (+11.15% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 2.78 · day 2.85–3.16 · 52w 2.75–16.34 · market cap $115M · ASE

## Key facts
- Analysts: Buy (mean 2.00 on a 1–5 scale) (2 analysts), mean target USD 17.5 (range 15–20).
- Total return with dividends: 1Y -11.5% vs S&P 500 +18.1%; 5Y -10.4% vs S&P 500 +85.1%.
- Next earnings: 2026-11-11, EPS estimate USD -0.56, revenue estimate $450K.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 2 analysts; mean target USD 17.5 (low 15, high 20).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-23 | HC Wainwright & Co. | Reiterated | Buy | $15 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -11.5% | -10.4% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -11.5% | -2.2% |
| Volatility (annualized) | 133.1% | 99.9% |
| Max drawdown | -81.2% (Apr 2026→Oct 2026) | -83.8% (Jan 2022→Apr 2025) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/ARMP · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt